BioHive
Évry, FR · Founded 2023 · 13 employees on LinkedIn · 3 known investors
Find your way into BioHive
1 people in our graph share verified history with the BioHive team — schools, employers, funds. One of them is your warm intro.
BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.
Founders & leadership
BioHive was founded in 2023 by Giulia, Cécile Naït, PhD, and Cesare Massart.
G
GiuliaCo-founder
CN
Cécile Naït, PhDinCo-founder & CEO
CM
Cesare MassartinCOO - Co-FounderCesare Massart previously served as Investment Director at 50 Partners, where he continues to work as a mentor, and is CEO of SOMNIUM. He sits on the board of En Carta Diagnostics, invests through Unhiders Angels, mentors for CNRS Innovation, and has served on the board of MEDICUD.
Investors · 3
Frequently asked questions
- What does BioHive do?
- BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.
- Who founded BioHive?
- BioHive was founded by Giulia, Cécile Naït, PhD, Cesare Massart in 2023.
- Who are BioHive's investors?
- BioHive's investors include 50 Partners, Kima Ventures, Teampact.ventures.
- Where is BioHive headquartered?
- BioHive is headquartered in Évry, FR.